论文部分内容阅读
骨髓增生异常综合征 (MDS)是一组起源于造血祖 /干细胞的获得性克隆性疾病。以全血细胞减少 ,骨髓病态造血和向白血病进展的高风险为特征。目前治疗方法较多 ,但缺乏有效治疗手段。本组采用环孢素 A (Cs A )联合治疗 MDS难治性贫血 (RA )患者 ,取得较好疗效。现将结果报道如下
Myelodysplastic syndrome (MDS) is a group of acquired clonal diseases that originate in hematopoietic progenitor / stem cells. Characterized by pancytopenia, myelopoietic hematopoiesis and high risk of progression to leukemia. The current treatment more, but the lack of effective treatment. This group of cyclosporine A (Cs A) combined treatment of MDS refractory anemia (RA) patients, and achieved good results. The results are reported below